Effects of insulin therapy with continuous subcutaneous insulin infusion (CSII) in diabetic patients: Comparison with multi-daily insulin injections therapy (MDI)

Endocrine Journal

Volumn 56, Issue 4, 2009, Pages 571-578

  Derosa, Giuseppe ^a   Maffioli, Pamela ^a   D'Angelo, Angela ^a   At Salvadeo, Sibilla ^a   Ferrari, Ilaria ^a   Fogari, Elena ^a   Mereu, Roberto ^a   Gravina, Alessia ^a   Palumbo, Ilaria ^a   Randazzo, Sabrina ^a   Cicero, Arrigo F G ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA GLUCOSIDASE INHIBITOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE DERIVATIVE; CALCIUM ANTAGONIST; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EZETIMIBE; FIBRIC ACID DERIVATIVE; GLITAZONE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN GLARGINE; INSULIN LISPRO; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SARTAN DERIVATIVE; SULFONYLUREA; TICLOPIDINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE COST; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEEDLE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; RESERVOIR; SYRINGE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 68449090863     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K08E-330     Document Type: Article

References (31)

1. Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.
2. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 352: 837-853.
3. Ohkubo Y, Kishikawa H, Araki E, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103-117.
4. Pickup J, Keen H (2002) Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 25: 593-598.
5. Nielsen S, Kain D, Szudzik E, Dhindsa S, Garg R, Dandona P (2005) Use of continuous subcutaneous insulin infusion pump in patients with type 2 diabetes mellitus. Diabetes Educ 31: 843-848. (Pubitemid 41771877)
6. Wainstein J, Metzger M, Boaz M, Minuchin O, Cohen Y, Yaffe A, Yerushalmy Y, Raz I, Harman-Boehm I (2005) Insulin pump therapy vs. multiple daily injections in obese type 2 diabetic patients. Diabet Med 22: 1037-1046. (Pubitemid 41026001)
7. Hsu SR, Lin SD, Tu ST, Liao PY, Su SL, Lin SL, Tseng YY, Huang PW (2008) Metabolic control with insulin pump therapy: preliminary experience. J Chin Med Assoc 71: 353-356.
8. Pickup J, Mattock M, Kerry S (2002) Glycaemic control with continuos subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. Br Med J 324: 705-710. (Pubitemid 34259145)
9. Li Y, Xu W, Liao Z (2004) Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care 27: 2597-2602. (Pubitemid 39441457)
10. Noh YH, Lee SM, Kim EJ, Kim DY, Lee H, Lee JH, Lee JH, Park SY, Koo JH, Wang JH, Lim IJ, Choi SB (2008) Improvement of cardiovascular risk factors in patients with type 2 diabetes after long-term continuous subcutaneous insulin infusion. Diabetes Metab Res Rev 24: 384-391.
11. Lepore G, Dodesini AR, Nosari I, Trevisan R (2003) both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment. Diabetes Care 26: 1321-1322. (Pubitemid 36929300)
12. Garg SK, Walker AJ, Hoff HK, D'Souza AO, Gottlieb PA, Chase HP (2004) Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump. Diabetes Technol Ther 6: 9-15.
13. 1c outcomes in Type 1 diabetic patients undergoing intensive diabetes management with preprandial rapid-acting insulin and either CSII or glargine. Diabetes Care 27: 272-273.
14. American Diabetes Association (2001) Nutrition recommendations and principles for people with diabetes mellitus (Position Statement). Diabetes Care 24: S44-S47.
15. King AB, Armstrong DU (2005) Basal bolus dosing: a clinical experience. Curr Diabetes Rev 1: 215-220.
16. Bode BW, Gross T, Ghegan MD (1999) Factors affecting the reduction of starting insulin dose in CSII. Diabetes 48 (Suppl 1): 264 (Abstract).
17. American Diabetes Association (2001) Screening for diabetes (Position Statement). Diabetes Care 24 (Suppl): S21-S24.
18. Bunn HF, Gabbay HK, Gallop PM (1978) The glycosylation of haemoglobin. Relevance to Diabetes Mellitus. Science 200: 21-27. (Pubitemid 8302924)
19. European Diabetes Policy Group (1999) A desktop guide to type 2 diabetes mellitus. Diab Med 16: 716-730.
20. Klose S, Borner K (1978) Enzymatische Bestimmung des Gesamtcholesterins mit dem Greiner Selective Analyzer (GSA II). J Clin Chem Clin Biochem 15: 121-130. (Pubitemid 8061822)
21. nd English ed. Academic Press, New York: 18-31.
22. Havel RJ, Edr HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353.
23. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
24. nd ed, McGraw-Hill, New York.
25. Schiaffini R, Patera PI, Bizzarri C, Ciampalini P, Cappa M (2007) Basal insulin supplementation in Type 1 diabetic children: a long-term comparative observational study between continuous subcutaneous insulin infusion and glargine insulin. J Endocrinol Invest 30 (7): 572-577. (Pubitemid 47577810)
26. Aberle I, Zimprich D, Bach-Kliegel B, Fischer C, Gorny M, Kliegel A, Langer K, Kliegel M (2008) Continuous subcutaneous insulin infusion leads to immediate, stable and long-term changes in metabolic control. Diabetes Obes Metab 10 (4): 329-335.
27. Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal Pos M, Girelli A, Lepore G, Aragona M, Iori E, Valentini U, Del Prato S, Tiengo A, Buhr A, Trevisan R, Baritussio A (2008) In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med 25 (3): 326-332. (Pubitemid 351322703)
28. Huang W, Liu YS, Wang YJ, Long LM, Li X, Wang Y, Yang Y (2008) A comparison of efficacy and safety in the treatment of hyperglycemia with continuous subcutaneous insulin with insulin pump or multiple insulin injections daily in critical elderly patients. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 20 (9): 546-549.
29. Pazin-Filho A, Kottgen A, Bertoni AG, Russell SD, Selvin E, Rosamond WD, Coresh J (2008) HbA(1c) as a risk factor for heart failure in persons with diabetes: the atherosclerosis risk in Communities (ariC) study. Diabetologia 51(12): 2197-2204.
30. Skogsberg L, Fors H, Hanas R, Chaplin JE, Lindman E, Skogsberg J (2008) Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus. Pediatr Diabetes 9 (5): 472-479.
31. Cohen N, Minshall ME, Sharon-Nash L, Zakrzewska K, Valentine WJ, Palmer AJ (2007) Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in australia. Pharmacoeconomics 25 (10): 881-897. (Pubitemid 47505012)